ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,282Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 403

$618K Total Retail Price of All Prescriptions

Rank: 24 out of 403

519 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,553 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 578 474 1 1
WARFARIN SODIUM 413 323 2 12
FUROSEMIDE 361 347 3 7
SIMVASTATIN 332 247 4 2
METOPROLOL TARTRATE 327 309 5 10
AMLODIPINE BESYLATE 313 266 6 4
LEVOTHYROXINE SODIUM 310 281 7 3
PRAVASTATIN SODIUM 308 270 8 14
HYDROCHLOROTHIAZIDE 304 277 9 6
ATENOLOL 274 227 10 13
OMEPRAZOLE 273 197 11 9
SERTRALINE HCL 222 206 12 20
ATORVASTATIN CALCIUM 184 163 13 5
MIRTAZAPINE 178 162 14 38
TAMSULOSIN HCL 168 161 15 27
METFORMIN HCL 163 132 16 8
LOVASTATIN 144 134 17 42
ALENDRONATE SODIUM 128 128 18 26
METOPROLOL SUCCINATE 127 112 19 11
PREDNISONE 123 114 20 34
ALLOPURINOL 121 121 21 31
DIOVAN 105 105 22 24
DONEPEZIL HCL 103 103 23 23
GABAPENTIN 98 97 24 17
RANITIDINE HCL 93 93 25 46
DOXAZOSIN MESYLATE 90 84 26 103
LOSARTAN POTASSIUM 88 75 27 21
PAROXETINE HCL 77 63 28 68
CARVEDILOL 72 57 29 32
TRAZODONE HCL 70 59 30 25
DIVALPROEX SODIUM 69 46 31 64
FONDAPARINUX SODIUM 68 68 32 227
CITALOPRAM HBR 68 35 32 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 62 34 29
SPIRIVA 64 58 35 35
NIFEDIPINE ER 63 62 36 122
CYMBALTA 63 55 36 43
LANTUS 63 54 36 54
NAMENDA 62 62 39 41
FLUTICASONE PROPIONATE 62 62 39 47
METFORMIN HCL ER 62 62 39 50
OLANZAPINE 62 50 39 77
POLYETHYLENE GLYCOL 3350 62 35 39 60
PANTOPRAZOLE SODIUM 61 57 44 30
HYDROCODONE-ACETAMINOPHEN 59 45 S3 45 15
PROPRANOLOL HCL 59 32 45 138
ZOLPIDEM TARTRATE 56 47 47 16
GLIPIZIDE 56 56 47 70
ENALAPRIL MALEATE 55 49 49 66
SPIRONOLACTONE 55 52 49 100
PLAVIX 53 53 51 83
PROAIR HFA 50 37 52 40
IBUPROFEN 50 41 52 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.